Джейн Плант - Антирак груди

Fisher, B., Bryant, J., Dignam, J. J., Wickerham, D. L., Mamounas, E. F., Fisher, E. R., Margolese, KG., Nesbitt, L., Paik, S., Pisansky, T. M., Wolmark, N., 2002. Tamoxifen, radiation therapy, or both for prevention of ipsilateral breast tumor recurrence after lumpectomy in women with invasive breast cancers of one centimeter or less. J. Clin. Oncol. , 20 (20), 4141–4149; www.ncbi.nlm.nih.gov;80

Fisher, B., Anderson, S., Bryant, J., Margolese, R. G., Deutsch, M., Fisher, E. R., Jeong, J. H. and Wolmark, N., 2002. Twenty-year follow-up of a randomised trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N. Engl. J. Med. , 347 (16), 1233–1241; www.ncbi.nlm.nih.gov;80

Gottlieb, Scott. Lumpectomy is as effective as mastectomy for breast cancer. BMJ , 325, 921.

www.nlm.nih.gov/medlineplus/ency/article/002919.htm

www.nlm.nih.gov/medlineplus/ency/article/002919.htm

www.cancer.org/docroot/cri/content/cri_2_6x_breast_reconstruction_after_mastectomy_5.asp

Bartelinkh and others, 2001. Recurrence rates after treatment of breast cancer with standard radiotherapy with or without additional radiation. New England J. Med. , 345 (19), 1378–1387.

http://cis.nci.nih.gov/fact/7_16.htm

Morrow, Monica and Gradishar, William, 2002. Recent Development: Breast Cancer. BMJ , 324, 410–414.

Coombes, R. C. and others, 2006. American Society of Clinical Oncology, Annual Meeting, Atlanta Georgia, June 2006.

Gralow, Julie R., 2002. Bisphosphonates as adjuvant treatment for breast cancer. BMJ , 325, 1051–1052.

www.gene.com/gene/products/information/oncology/herceptin; www.herceptin.com/herceptin/physician/pi.htm

www.herceptin.com/herceptin/physician/pi.htm

Anon, 2006. Patient is to appeal High Court ruling on breast cancer drug. BMJ , 332–443.

Barrett, A. and others, 2006. How much will herceptin really cost? BMJ , 333, 1118–1120.

Daily Mail , Monday, 9 October, 2006.

www.ahrq.gov/news/press/pr2002/brchempr.htm

www.ahrq.gov/news/press/pr2002/brchempr.htm

http://cis.nci.nih.gov/fact/7_16.htm

Gottlieb, Scott, 2002. Tamoxifen may increase risk of uterine sarcoma, BMJ , 325, 7.

http://cis.nci.nih.gov/fact/7_16.htm

Mayor, Susan, 2002. Anastrozole shows promise for early breast cancer. BMJ , 324, 1539

www.gene.com/gene/products/information/oncology/herceptin; www.herceptin.com/herceptin/physician/pi.htm

http://cis.nci.nih.gov/fact/7_45.htm

New Scientist , 20 January, 2007.

Editorial, New Scientist , 31 March, 2007.

Josefson, Deborah, 2002. Doctors warned to be wary of new drugs. BMJ , 324, 1113.

Garattini, Silvio and Bertele, Vittorio, 2002. Efficacy, safety, and cost of new anticancer drugs. BMJ , 325, 269–271.

www.cancer.gov

Modified after: Chemotherapy and You: A Guide to Self-Help During Cancer Treatment. Information about what to expect during chemotherapy and what patients can do to take care of themselves during and after treatment NIH Publication #99 – 1136: www.cancer.gov/cancerinfo/chemorherapy-and-you

Smith, I. and Chue, S., 2006. Medical treatment of early breast cancer. BMJ , 332, 162–181.

Allison, R. and others, 2006. Photodiagnosis and photodynamic therapy, 3, 139–146.

Fritsch, C. and Ruzika, T., 2003. Fluorescence diagnosis and photodynamic therapy of skin diseases atlas and handbook. Vien: Springer-Verlag.

Абляция (лат. ablatio – отнятие) – специфическое хирургическое вмешательство; абляция подразумевает под собой выжигание или выпаривание дисфункциональной или патологически измененной ткани с использованием лазера, радиочастотного аппарата, тока или химии; также данная операция может проводиться классическим хирургическим вмешательством. – Примеч. ред.

Coulter; Angela, 2003. Killing the goose that laid the golden egg. BMJ , 326, 1280.

Coulter, Angela, 2003. Killing the goose that laid the golden egg. BMJ , 326, 1280.

Ernst, E., 2003. Herbal medicines put into context. BMJ , 327, 881–882.

Waxman, Jonathan, 2001. The Prostate Cancer Book . London: Vermillion.

Dyer, Owen, 2003. Aspirin could be used to prevent cancer. BMJ , 326, 565.

Flower, Rod, 2003. What are all the things that aspirin does? BMJ , 327, 572–573.

UK limits use of aspirin by under 16s. BMJ , 2002, 324, 1294.

Astralagus. ICON , 2002, 1 (3), 23.

Bartram, T., 1998. Bartram's encyclopedia of herbal medicine . Robinson publishing.

Campbell, T. C. and Campbell, T. M., 2006. The China Study . Benbella Books.

Рейки – вид комплементарной медицины, в котором используется техника так называемого исцеления путем наложения рук. – Примеч. ред.

Greenwald, Peter, 2002. Cancer chemoprevention. BMJ , 324, 714–718.

Clarke, M.F. and Becker, M.W., 2006. Stem cells: the real culprits in cancer? Scientific American , July 2006, 53–59.

Study reveals how growth factors affect human stem cells. www.hhmi.org/news/melton.hmtl

Murray, R.K., Granner, D.K., Mayes, P.A. and Rodwell, V.W., 1990. Harper's Biochemistry . Appleton and Lange Norwalk, CT, p. 653.

Woolf, Neville, 1998. Pathology, Basic and Systemic . W.B. Saunders Publishing Co., Chapter 28, p. 274, Figure 28.

www.intouchlive.com/cancergenetics/onco.htm

Ludwig, T., Fisher, P., Ganesan, S. and Efstratiadis, 2001. Tumorigenesis in mice carrying a truncating BRCA1 mutation. Genes and Development , Vol. 15 (10), 1188–1193.

Xu, X., Wagner, K.U., Larson, D., Weaver, Z., Li, C., Ried, T., Hennighausen, L., Wynshaw-Boris, A. and Deng, C.X. 1999. Conditional mutation of BRCA1 in mammary epithelial cells results in blunted ductal morphogenesis and tumour formation. Nature Genetics , Vol. 22 (1), 37–43.

Paull, T.T, Cortez, D., Bowers, B., Elledge, S.J. and Gellert, M., 2001. Direct DNA binding by BRCA1. Proceedings of the National Academy of Sciences of the USA , Vol. 98 (11), 6086–6091.

Jensen, R.A., Thompson, M.E., Jetton, T.L., Szabo, C.I., van der Meer, R., Helou, B., Tronick, S., King, M.C., Page, D.L. and Holt, J.T., 1996. BRCA1 is secreted and exhibits properties of a granin. Nature Genetics , 12, 303–308; www.mc.vanderbilt.edu/cancer/research/roster/jensen.html

Struewing, J.P., Abeliovich, D., Peretz, T., Avishai, N., Kaback, M.M., Collins, F.S. and Brody, L.C., 1995. The carrier frequency of the BRCA1 185delAG mutation is approximately 1 percent in Ashkenazi-Jewish individuals. Nature Genetics , 11, 198–200; http://rex.nci.nih.gov/massmedia/back-grounders/ashkenazi.html

Roa, B.B., Boyd, A.A., Volcik, K. and Richards, C.S., 1996. Ashkenazi Jewish population frequencies for common mutations in BRCA1 and BRCA2. Nature Genetics , 14, 185–187; Oddoux, C., Struewing, J.P., Clayton, C.M., Neuhausen, S., Vrody, L.C., Kaback, M., Haas, B., Norton, L., Borgen, P. Jhanwar, S., Golgar, D., Ostrer, H. and Offit, K., 1996. The carrier frequency of the BRCA2 6174delT mutation among Ashkenazi Jewish individuals is approximately 1 %. Nature Genetics , 14, 188–190; http://rex.nci.nih.gov/massmedia/backgrounders/ashkenazi.html

www.mercola.com/2002/apr/27/sv40.htm

Hursting, S.D., Slaga,T.J., Fischer, S.M., DiGiovanni, J. and Phtans, J. M., 1999. Mechanism-based cancer prevention approaches: targets, examples, and the use of transgenic mice. Journal of the National Cancer Institute , 35, 2031–2038.

Cheeseman, K.H. and Slater, T.F., 1993. Free Radicals in Medicine . Churchill Livingston.

Cheeseman, K.H. and Slater, T.F., 1993. Free Radicals in Medicine . Churchill Livingston.

Stewart, H.J., 1989. Clinical experience in the use of antioestrogen tamoxifen in the treatment of breast cancer. Proceedings of the Royal Society of Edinburgh , 95B, 231–237.

Miller, W. R., 1997. Aromatase inhibitors and breast cancer. Cancer Treatment Reviews , 23, 113–131.

Dao, T.L., Sinha, D.K., Nemato, T. and Patel, J., 1982. Effects of estrogens and progesterone on cellular replication of human breast tumours. Cancer Research , 42, 359–362.

Conte, P.P., Fraschini, G. and Dewinko, B., 1985. Estrogen induced expansion of the growth fraction in receptor negative human breast cancer. Journal of Steroid Biochemistry , 23, 1169–1172.

Miller, W.R. and Langdon, S.P., 1997. Hormonal, growth factor and cytokine control of breast cancer. In: Biology of Female Cancers , pp. 43–60. Langdon, S,P., Miller, W.R. and Berchuck, A. (editors). New York: CRC Press.

Miller, W.R., 1991. Oestrogens and breast cancer: biological considerations, British Medical Bulletin , 47, 470–483.

Yu, H. and Rohan, T., 2002. Role of the insulin-like growth factor family in cancer development and progression. J. Natl Cancer Inst , 92, 1472–1489.